×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Endocyte (ECYT) Soars: Stock Adds 11.4% in Session
Yahoo Life UK
Endocyte (ECYT) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.
2 weeks ago
Endocyte becomes first Purdue startup to reach $1.5B in value
Purdue University
Endocyte becomes first Purdue startup to reach $1.5B in value. Endocyte's primary cancer drug platforms include “two of the most exciting...
67 months ago
ASCO: Novartis backs up $2.1B Endocyte buyout with prostate cancer data
Fierce Biotech
More than two years after splashing out $2.1 billion on Endocyte, Novartis is pulling the curtain on full phase 3 data for the...
35 months ago
Endocyte (ECYT): What Awaits the Stock in Q1 Earnings?
Yahoo Movies UK
Endocyte, Inc. (ECYT) is slated to report first-quarter 2016 results on May 4.
2 weeks ago
Radiopharmaceuticals Bring in Big Money to Target Irreversible Tumor Damage
BioSpace
Once dormant due to a lack of commercial success and drug side effects, the radiopharmaceutical space is gaining momentum in the form of...
4 months ago
Purdue startup Endocyte sold in $2.1B deal with Novartis
Journal & Courier
Endocyte, based in West Lafayette, has been chasing a targeted drug to cure prostate cancer. Novartis deal announced Thursday.
67 months ago
Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion
WSJ
Deal is latest by new chief executive to reshape Swiss pharmaceutical giant ... Novartis AG on Thursday said it would pay $2.1 billion for...
67 months ago
West Lafayette-Based Endocyte Aquired For $2.1 Billion By Pharma Giant Novartis
WFYI
Samantha Horton ... Swiss pharmaceutical giant Novartis says it will acquire West Lafayette-based Endocyte for $2.1 billion. Endocyte was founded...
67 months ago
Cancer drug discovered in Indiana to power Indy Novartis plant – Inside INdiana Business
Inside INdiana Business
The media could not be loaded, either because the server or network failed or because the format is not supported.
5 months ago
Novartis to Acquire Endocyte for $2.1B, Expanding RLT Pipeline in Prostate Cancer
Genetic Engineering and Biotechnology News
Novartis has agreed to acquire Endocyte for $2.1 billion, the companies said today, in a deal that expands the buyer's radioligand therapy...
67 months ago